| Literature DB >> 25158842 |
N Bessimbaye1, A M Moussa, D Mbanga, A Tidjani, S O Mahamat, M Nahor Ngawara, G Ngarnayal, H Y Fissou, L Sangare, G Ndoutamia, N Barro.
Abstract
This is a prospective study conducted as part of a voluntary testing for HBV, HCV and HIV. The aim of the study is to determine the seroprevalence of HBs Ag and anti-HCV antibodies among HIV infected people and a control group of HIV negative people. HIV prevalence among newly diagnosed volunteers is 9.1%. The overall seroprevalence of HBs Ag and anti-HCV antibodies is respectively 13.5% and 2.0%. The seroprevalence of HBs Ag and anti-HCVantibodies in the control group (HIV-negative) is respectively 12.2% and 2%. The seroprevalence of HBs Ag and anti-HCV antibodies among HIV infected people (old and new) is respectively 16.1% and 1%.This study, the first one conducted in Chad, has allowed us to know the seroprevalence of HBs Ag and anti-HCV antibodies among HIV infected people.Entities:
Mesh：
Substances：
Year: 2014 PMID： 25158842 DOI： 10.1007/s13149-014-0386-1
Source DB: PubMed Journal: Bull Soc Pathol Exot ISSN： 0037-9085